R&D Tax Relief for Loss-Making Businesses

    Understand how R&D tax relief may support your loss-making business. This free guide compares merged RDEC and ERIS, explains eligibility and payment restrictions, and includes worked examples to help you understand a potential claim.

    Access Your Free Guide

    Enter your details to access this comprehensive guide on R&D tax relief for loss-making businesses

    Making a loss does not automatically prevent a company from receiving R&D tax support. But a loss does not, by itself, establish eligibility or guarantee a cash payment.

    The answer depends on your accounting period, the R&D activity and costs, the scheme you qualify for, and the restrictions that apply to your claim. The merged R&D expenditure credit and Enhanced R&D Intensive Support work differently.

    Start with the accounting period

    For accounting periods beginning on or after 1 April 2024, the main routes are the merged R&D expenditure credit scheme, often called merged RDEC, and Enhanced R&D Intensive Support, or ERIS.

    Earlier accounting periods use the then-applicable old RDEC or SME rules. A year ending after 1 April 2024 does not automatically fall into the new schemes: a period from 1 January to 31 December 2024 began before that date, whereas a period from 1 January to 31 December 2025 began afterwards.

    Read which R&D scheme applies and HMRC’s merged-scheme and ERIS guidance before applying a rate.

    Merged RDEC: a taxable expenditure credit

    Merged RDEC is generally a 20% taxable credit on qualifying expenditure for eligible trading companies. The gross credit is not the same as an immediate cash payment.

    The payment steps can use credit against Corporation Tax and other HMRC liabilities. They also apply a notional-tax restriction and a PAYE/National Insurance cap unless an exemption applies. Amounts may be carried forward or used elsewhere under the rules instead of paid straight to the company.

    For a loss-maker of the kind illustrated below, the applicable notional-tax rate is 19%. Do not assume that being loss-making removes all tax-related restrictions. See HMRC’s payment steps.

    ERIS: an additional deduction and a possible loss surrender

    ERIS is for eligible loss-making R&D-intensive SMEs. A trading company must have a trading loss for tax purposes before the additional R&D deduction; a loss shown in the accounts alone is not enough.

    The standard intensity condition is relevant R&D expenditure of at least 30% of total relevant expenditure. Connected-company expenditure must be considered, so this is not always the percentage visible in your own company’s accounts. The R&D SME definition also has its own rules; a small-company filing classification is not decisive. A grace-period rule may help some companies that met the intensity condition and made an eligible claim in their previous 12-month accounting period.

    For qualifying expenditure, ERIS provides an additional deduction of 86%, on top of the ordinary deduction already taken. A company may then surrender an eligible loss for a 14.5% payable credit.

    The surrenderable amount is the lower of:

    • 186% of the qualifying expenditure for which the additional deduction was taken; and
    • The current-period unrelieved trading loss after the relevant adjustments.

    Other income and loss-relief use can reduce the surrenderable amount. The PAYE cap may also limit the credit. You do not receive both a cash credit and future tax relief for the same surrendered loss. See HMRC’s ERIS calculation.

    The often-quoted maximum of approximately 27% is 186% × 14.5% = 26.97% of qualifying expenditure. That assumes the company can surrender the full enhanced expenditure and the credit is not restricted. It is not the cash percentage every eligible company receives; the ERIS example below produces a lower amount because its surrenderable loss is smaller.

    Two fictional examples

    Both examples use a 12-month accounting period from 1 January to 31 December 2025. The companies are registered in England, have no connected companies and have qualifying UK R&D activity. Relevant costs have been paid. Each has £10,000 of relevant PAYE/NIC liabilities, giving a £50,000 cap: £20,000 + 300% × £10,000.

    Assume both meet the other claim and going-concern conditions, have no other income or HMRC debts, and no enquiry or other restriction prevents payment. These are different companies, not a like-for-like promise about which scheme is better.

    A company using merged RDEC

    Company A has £100,000 of qualifying expenditure, £400,000 of total relevant expenditure and a £50,000 trading loss before the expenditure credit. Its R&D intensity is 25%; assume it has no entitlement to the ERIS grace period.

    Scroll the table horizontally to see all columns.

    A company using merged RDEC
    CalculationWorkingResult
    Gross expenditure credit£100,000 × 20%£20,000
    Trading loss after the taxable credit£50,000 loss less £20,000 credit income£30,000 loss
    Current-period Corporation Tax offsetNo taxable profits on the stated facts£0
    Step 2 notional-tax restriction£20,000 × 19%(£3,800)
    Amount remaining after step 2£20,000 − £3,800£16,200
    PAYE cap£20,000 + 3 × £10,000£50,000
    Illustrative current cash paymentNo further offsets or restrictions on the stated facts£16,200

    The £3,800 step 2 restriction is carried forward to discharge future Corporation Tax under the applicable rules; it is not described here as a separate cash payment. The company also retains a different loss position after recognising the taxable credit. The illustration is not a promise about its lifetime tax benefit.

    A company that qualifies for ERIS

    Company B is an eligible SME with £100,000 of qualifying expenditure, £300,000 of total relevant expenditure and a £50,000 unrelieved trading loss before the additional deduction. Its R&D intensity is £100,000 ÷ £300,000 = approximately 33.33%, above 30%.

    Scroll the table horizontally to see all columns.

    A company that qualifies for ERIS
    CalculationWorkingResult
    Additional deduction£100,000 × 86%£86,000
    Trading loss after additional deduction£50,000 + £86,000£136,000
    Enhanced expenditure ceiling£100,000 × 186%£186,000
    Surrenderable lossLower of £136,000 and £186,000£136,000
    Payable credit before the cap£136,000 × 14.5%£19,720
    PAYE cap£20,000 + 3 × £10,000£50,000
    Illustrative payable creditCap does not restrict the amount£19,720

    If Company B surrenders all £136,000, that surrendered loss is no longer available for later relief. The example shows why applying 14.5% to 186% of expenditure without checking the actual unrelieved loss can overstate the cash amount.

    Both examples follow HMRC’s calculation guidance. A company eligible for ERIS may choose merged RDEC instead, but cannot claim both schemes on the same costs.

    Check the activity and the costs, not just the loss

    The project must meet the R&D definition, including a qualifying scientific or technological advance and uncertainty. Work being commercially new or difficult for your business is not enough by itself.

    Potential qualifying costs include the appropriate R&D share of staff costs, eligible externally provided workers, consumables, software, and qualifying data/cloud costs. Contractor payments have additional entitlement, connection, percentage and payment rules. Not all business costs qualify, and grant funding or a customer contract needs examination under the rules for the period.

    For periods beginning on or after 1 April 2024, overseas contractor and externally provided worker expenditure is generally restricted. Contractor activity generally needs to be in the UK unless the strict necessary-conditions exception applies; externally provided worker costs have specific PAYE/NIC rules. Lower overseas costs or the availability of workers abroad do not alone establish the exception. Northern Ireland ERIS has special overseas-expenditure and State aid provisions, so separate advice may be needed.

    Use HMRC’s qualifying-cost guidance and overseas-restriction guidance, rather than including all development spending automatically.

    Prepare the evidence and check the deadlines

    Keep project dates, the scientific or technological uncertainty, the competent professionals’ explanation, work undertaken and results; a reconciled cost breakdown; contracts and invoices; payment records; accounts and tax-loss calculations; and PAYE/NIC and connected-company information.

    Claims must generally be made within two years of the end of the accounting period.

    Claim Notification Form: current rules and announced change

    Current requirements before 1 April 2027: Check whether a Claim Notification Form is required for the intended claim. For accounting periods beginning on or after 1 April 2023, notification can be required for first-time claimants and some companies that have claimed previously. Previous claims, exceptions and the submission date matter. Where notification is required, its deadline is generally six months after the end of the period of account, not the ordinary Company Tax Return deadline. A missed requirement can invalidate a claim.

    Announced change for claims made on or after 1 April 2027: The government has announced abolition of the Claim Notification Form requirement for claims made from that date. HMRC's guidance already describes that future position. The government's policy paper describes amendments to be made through the Finance Bill; this is an announced future change, not a statement that the notification requirement has already ended.

    The announced date concerns when the claim is made, not simply when the accounting period starts or ends. Continue to follow the applicable current requirements, and confirm the enacted legislation and transitional rules before relying on the future removal. Do not assume waiting until April 2027 will preserve a claim or repair a missed notification: ordinary claim deadlines and the particular facts still need checking.

    Read HMRC's notification guidance and the government's announcement and proposed revisions together.

    The additional information form is separate

    The separate additional information form must be submitted before the Company Tax Return containing the claim. Read which records support a claim before starting the submission process.

    The announced abolition of claim notification does not abolish the additional information form or remove the underlying R&D eligibility and evidence requirements.

    This page focuses on trading companies. Pre-trading expenditure and other special cases need their own assessment.

    This guide is general information. Eligibility, claim value and payment timing depend on the company’s facts and the applicable rules.

    Get your free guide

    For advice on your company’s accounting period, projects and tax-loss position, speak to our R&D specialists.